White, 64, has made Abbott a dominant player in medical technology, reshaping the company with a series of mergers and other deals as it confronted the rise of the digital age and the miniaturization of medical devices. Over his long tenure, Abbott’s shares have roughly quintupled in value.
White will remain executive chairman of Abbott’s board of directors after he steps down as CEO effective March ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.